Global Giant Cell Arteritis Therapeutic Market Research Report 2025(Status and Outlook)
Report Overview
Giant cell arteritis (GCA) is a granulomatous medium and large-vessel vasculitis. It is the most common form of systemic vasculitis, with an incidence of between 15 and 25 cases per 100,000 persons over 50 years of age.
The global Giant Cell Arteritis Therapeutic market size was estimated at USD 1046.5 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Giant Cell Arteritis Therapeutic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Giant Cell Arteritis Therapeutic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Giant Cell Arteritis Therapeutic market
Global Giant Cell Arteritis Therapeutic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
Kiniksa PharmaceuticalsLtd.
Regeneron
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd.
Novartis AG
AbbVieInc.
Bristol-Myers Squibb Company
Abbott
Johnson & Johnson ServicesInc.
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
Market Segmentation (by Type)
Prednisone
Methotrexate
Tocilizumab
Aspirin
Market Segmentation (by Application)
Corticosteroids
Immunosuppressive Agents
Anticoagulants
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Giant Cell Arteritis Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Giant Cell Arteritis Therapeutic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Giant cell arteritis (GCA) is a granulomatous medium and large-vessel vasculitis. It is the most common form of systemic vasculitis, with an incidence of between 15 and 25 cases per 100,000 persons over 50 years of age.
The global Giant Cell Arteritis Therapeutic market size was estimated at USD 1046.5 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Giant Cell Arteritis Therapeutic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Giant Cell Arteritis Therapeutic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Giant Cell Arteritis Therapeutic market
Global Giant Cell Arteritis Therapeutic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
Kiniksa PharmaceuticalsLtd.
Regeneron
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd.
Novartis AG
AbbVieInc.
Bristol-Myers Squibb Company
Abbott
Johnson & Johnson ServicesInc.
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
Market Segmentation (by Type)
Prednisone
Methotrexate
Tocilizumab
Aspirin
Market Segmentation (by Application)
Corticosteroids
Immunosuppressive Agents
Anticoagulants
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Giant Cell Arteritis Therapeutic Market
- Overview of the regional outlook of the Giant Cell Arteritis Therapeutic Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Giant Cell Arteritis Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Giant Cell Arteritis Therapeutic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Giant Cell Arteritis Therapeutic
1.2 Key Market Segments
1.2.1 Giant Cell Arteritis Therapeutic Segment by Type
1.2.2 Giant Cell Arteritis Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GIANT CELL ARTERITIS THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Giant Cell Arteritis Therapeutic Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Giant Cell Arteritis Therapeutic Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GIANT CELL ARTERITIS THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Giant Cell Arteritis Therapeutic Product Life Cycle
3.3 Global Giant Cell Arteritis Therapeutic Sales by Manufacturers (2020-2025)
3.4 Global Giant Cell Arteritis Therapeutic Revenue Market Share by Manufacturers (2020-2025)
3.5 Giant Cell Arteritis Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Giant Cell Arteritis Therapeutic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Giant Cell Arteritis Therapeutic Market Competitive Situation and Trends
3.8.1 Giant Cell Arteritis Therapeutic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Giant Cell Arteritis Therapeutic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GIANT CELL ARTERITIS THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Giant Cell Arteritis Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GIANT CELL ARTERITIS THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Giant Cell Arteritis Therapeutic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Giant Cell Arteritis Therapeutic Market
5.7 ESG Ratings of Leading Companies
6 GIANT CELL ARTERITIS THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Giant Cell Arteritis Therapeutic Sales Market Share by Type (2020-2025)
6.3 Global Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2020-2025)
6.4 Global Giant Cell Arteritis Therapeutic Price by Type (2020-2025)
7 GIANT CELL ARTERITIS THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Giant Cell Arteritis Therapeutic Market Sales by Application (2020-2025)
7.3 Global Giant Cell Arteritis Therapeutic Market Size (M USD) by Application (2020-2025)
7.4 Global Giant Cell Arteritis Therapeutic Sales Growth Rate by Application (2020-2025)
8 GIANT CELL ARTERITIS THERAPEUTIC MARKET SALES BY REGION
8.1 Global Giant Cell Arteritis Therapeutic Sales by Region
8.1.1 Global Giant Cell Arteritis Therapeutic Sales by Region
8.1.2 Global Giant Cell Arteritis Therapeutic Sales Market Share by Region
8.2 Global Giant Cell Arteritis Therapeutic Market Size by Region
8.2.1 Global Giant Cell Arteritis Therapeutic Market Size by Region
8.2.2 Global Giant Cell Arteritis Therapeutic Market Size Market Share by Region
8.3 North America
8.3.1 North America Giant Cell Arteritis Therapeutic Sales by Country
8.3.2 North America Giant Cell Arteritis Therapeutic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Giant Cell Arteritis Therapeutic Sales by Country
8.4.2 Europe Giant Cell Arteritis Therapeutic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Giant Cell Arteritis Therapeutic Sales by Region
8.5.2 Asia Pacific Giant Cell Arteritis Therapeutic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Giant Cell Arteritis Therapeutic Sales by Country
8.6.2 South America Giant Cell Arteritis Therapeutic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Giant Cell Arteritis Therapeutic Sales by Region
8.7.2 Middle East and Africa Giant Cell Arteritis Therapeutic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GIANT CELL ARTERITIS THERAPEUTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Giant Cell Arteritis Therapeutic by Region(2020-2025)
9.2 Global Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2020-2025)
9.3 Global Giant Cell Arteritis Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Giant Cell Arteritis Therapeutic Production
9.4.1 North America Giant Cell Arteritis Therapeutic Production Growth Rate (2020-2025)
9.4.2 North America Giant Cell Arteritis Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Giant Cell Arteritis Therapeutic Production
9.5.1 Europe Giant Cell Arteritis Therapeutic Production Growth Rate (2020-2025)
9.5.2 Europe Giant Cell Arteritis Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Giant Cell Arteritis Therapeutic Production (2020-2025)
9.6.1 Japan Giant Cell Arteritis Therapeutic Production Growth Rate (2020-2025)
9.6.2 Japan Giant Cell Arteritis Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Giant Cell Arteritis Therapeutic Production (2020-2025)
9.7.1 China Giant Cell Arteritis Therapeutic Production Growth Rate (2020-2025)
9.7.2 China Giant Cell Arteritis Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Giant Cell Arteritis Therapeutic Product Overview
10.1.3 Sanofi Giant Cell Arteritis Therapeutic Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 Kiniksa PharmaceuticalsLtd.
10.2.1 Kiniksa PharmaceuticalsLtd. Basic Information
10.2.2 Kiniksa PharmaceuticalsLtd. Giant Cell Arteritis Therapeutic Product Overview
10.2.3 Kiniksa PharmaceuticalsLtd. Giant Cell Arteritis Therapeutic Product Market Performance
10.2.4 Kiniksa PharmaceuticalsLtd. Business Overview
10.2.5 Kiniksa PharmaceuticalsLtd. SWOT Analysis
10.2.6 Kiniksa PharmaceuticalsLtd. Recent Developments
10.3 Regeneron
10.3.1 Regeneron Basic Information
10.3.2 Regeneron Giant Cell Arteritis Therapeutic Product Overview
10.3.3 Regeneron Giant Cell Arteritis Therapeutic Product Market Performance
10.3.4 Regeneron Business Overview
10.3.5 Regeneron SWOT Analysis
10.3.6 Regeneron Recent Developments
10.4 GlaxoSmithKline plc
10.4.1 GlaxoSmithKline plc Basic Information
10.4.2 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Overview
10.4.3 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Market Performance
10.4.4 GlaxoSmithKline plc Business Overview
10.4.5 GlaxoSmithKline plc Recent Developments
10.5 F. Hoffmann-La Roche Ltd.
10.5.1 F. Hoffmann-La Roche Ltd. Basic Information
10.5.2 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Overview
10.5.3 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Market Performance
10.5.4 F. Hoffmann-La Roche Ltd. Business Overview
10.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.6 Novartis AG
10.6.1 Novartis AG Basic Information
10.6.2 Novartis AG Giant Cell Arteritis Therapeutic Product Overview
10.6.3 Novartis AG Giant Cell Arteritis Therapeutic Product Market Performance
10.6.4 Novartis AG Business Overview
10.6.5 Novartis AG Recent Developments
10.7 AbbVieInc.
10.7.1 AbbVieInc. Basic Information
10.7.2 AbbVieInc. Giant Cell Arteritis Therapeutic Product Overview
10.7.3 AbbVieInc. Giant Cell Arteritis Therapeutic Product Market Performance
10.7.4 AbbVieInc. Business Overview
10.7.5 AbbVieInc. Recent Developments
10.8 Bristol-Myers Squibb Company
10.8.1 Bristol-Myers Squibb Company Basic Information
10.8.2 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Overview
10.8.3 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Market Performance
10.8.4 Bristol-Myers Squibb Company Business Overview
10.8.5 Bristol-Myers Squibb Company Recent Developments
10.9 Abbott
10.9.1 Abbott Basic Information
10.9.2 Abbott Giant Cell Arteritis Therapeutic Product Overview
10.9.3 Abbott Giant Cell Arteritis Therapeutic Product Market Performance
10.9.4 Abbott Business Overview
10.9.5 Abbott Recent Developments
10.10 Johnson and Johnson ServicesInc.
10.10.1 Johnson and Johnson ServicesInc. Basic Information
10.10.2 Johnson and Johnson ServicesInc. Giant Cell Arteritis Therapeutic Product Overview
10.10.3 Johnson and Johnson ServicesInc. Giant Cell Arteritis Therapeutic Product Market Performance
10.10.4 Johnson and Johnson ServicesInc. Business Overview
10.10.5 Johnson and Johnson ServicesInc. Recent Developments
10.11 Johns Hopkins Hospital
10.11.1 Johns Hopkins Hospital Basic Information
10.11.2 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Overview
10.11.3 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Market Performance
10.11.4 Johns Hopkins Hospital Business Overview
10.11.5 Johns Hopkins Hospital Recent Developments
10.12 Fortis Healthcare
10.12.1 Fortis Healthcare Basic Information
10.12.2 Fortis Healthcare Giant Cell Arteritis Therapeutic Product Overview
10.12.3 Fortis Healthcare Giant Cell Arteritis Therapeutic Product Market Performance
10.12.4 Fortis Healthcare Business Overview
10.12.5 Fortis Healthcare Recent Developments
10.13 American College of Rheumatology
10.13.1 American College of Rheumatology Basic Information
10.13.2 American College of Rheumatology Giant Cell Arteritis Therapeutic Product Overview
10.13.3 American College of Rheumatology Giant Cell Arteritis Therapeutic Product Market Performance
10.13.4 American College of Rheumatology Business Overview
10.13.5 American College of Rheumatology Recent Developments
10.14 Duke University Health System
10.14.1 Duke University Health System Basic Information
10.14.2 Duke University Health System Giant Cell Arteritis Therapeutic Product Overview
10.14.3 Duke University Health System Giant Cell Arteritis Therapeutic Product Market Performance
10.14.4 Duke University Health System Business Overview
10.14.5 Duke University Health System Recent Developments
10.15 Lahey Clinic Foundation
10.15.1 Lahey Clinic Foundation Basic Information
10.15.2 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Overview
10.15.3 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Market Performance
10.15.4 Lahey Clinic Foundation Business Overview
10.15.5 Lahey Clinic Foundation Recent Developments
11 GIANT CELL ARTERITIS THERAPEUTIC MARKET FORECAST BY REGION
11.1 Global Giant Cell Arteritis Therapeutic Market Size Forecast
11.2 Global Giant Cell Arteritis Therapeutic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Giant Cell Arteritis Therapeutic Market Size Forecast by Country
11.2.3 Asia Pacific Giant Cell Arteritis Therapeutic Market Size Forecast by Region
11.2.4 South America Giant Cell Arteritis Therapeutic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Giant Cell Arteritis Therapeutic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Giant Cell Arteritis Therapeutic Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Giant Cell Arteritis Therapeutic by Type (2026-2033)
12.1.2 Global Giant Cell Arteritis Therapeutic Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Giant Cell Arteritis Therapeutic by Type (2026-2033)
12.2 Global Giant Cell Arteritis Therapeutic Market Forecast by Application (2026-2033)
12.2.1 Global Giant Cell Arteritis Therapeutic Sales (K MT) Forecast by Application
12.2.2 Global Giant Cell Arteritis Therapeutic Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Giant Cell Arteritis Therapeutic
1.2 Key Market Segments
1.2.1 Giant Cell Arteritis Therapeutic Segment by Type
1.2.2 Giant Cell Arteritis Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GIANT CELL ARTERITIS THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Giant Cell Arteritis Therapeutic Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Giant Cell Arteritis Therapeutic Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GIANT CELL ARTERITIS THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Giant Cell Arteritis Therapeutic Product Life Cycle
3.3 Global Giant Cell Arteritis Therapeutic Sales by Manufacturers (2020-2025)
3.4 Global Giant Cell Arteritis Therapeutic Revenue Market Share by Manufacturers (2020-2025)
3.5 Giant Cell Arteritis Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Giant Cell Arteritis Therapeutic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Giant Cell Arteritis Therapeutic Market Competitive Situation and Trends
3.8.1 Giant Cell Arteritis Therapeutic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Giant Cell Arteritis Therapeutic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GIANT CELL ARTERITIS THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Giant Cell Arteritis Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GIANT CELL ARTERITIS THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Giant Cell Arteritis Therapeutic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Giant Cell Arteritis Therapeutic Market
5.7 ESG Ratings of Leading Companies
6 GIANT CELL ARTERITIS THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Giant Cell Arteritis Therapeutic Sales Market Share by Type (2020-2025)
6.3 Global Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2020-2025)
6.4 Global Giant Cell Arteritis Therapeutic Price by Type (2020-2025)
7 GIANT CELL ARTERITIS THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Giant Cell Arteritis Therapeutic Market Sales by Application (2020-2025)
7.3 Global Giant Cell Arteritis Therapeutic Market Size (M USD) by Application (2020-2025)
7.4 Global Giant Cell Arteritis Therapeutic Sales Growth Rate by Application (2020-2025)
8 GIANT CELL ARTERITIS THERAPEUTIC MARKET SALES BY REGION
8.1 Global Giant Cell Arteritis Therapeutic Sales by Region
8.1.1 Global Giant Cell Arteritis Therapeutic Sales by Region
8.1.2 Global Giant Cell Arteritis Therapeutic Sales Market Share by Region
8.2 Global Giant Cell Arteritis Therapeutic Market Size by Region
8.2.1 Global Giant Cell Arteritis Therapeutic Market Size by Region
8.2.2 Global Giant Cell Arteritis Therapeutic Market Size Market Share by Region
8.3 North America
8.3.1 North America Giant Cell Arteritis Therapeutic Sales by Country
8.3.2 North America Giant Cell Arteritis Therapeutic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Giant Cell Arteritis Therapeutic Sales by Country
8.4.2 Europe Giant Cell Arteritis Therapeutic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Giant Cell Arteritis Therapeutic Sales by Region
8.5.2 Asia Pacific Giant Cell Arteritis Therapeutic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Giant Cell Arteritis Therapeutic Sales by Country
8.6.2 South America Giant Cell Arteritis Therapeutic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Giant Cell Arteritis Therapeutic Sales by Region
8.7.2 Middle East and Africa Giant Cell Arteritis Therapeutic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GIANT CELL ARTERITIS THERAPEUTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Giant Cell Arteritis Therapeutic by Region(2020-2025)
9.2 Global Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2020-2025)
9.3 Global Giant Cell Arteritis Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Giant Cell Arteritis Therapeutic Production
9.4.1 North America Giant Cell Arteritis Therapeutic Production Growth Rate (2020-2025)
9.4.2 North America Giant Cell Arteritis Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Giant Cell Arteritis Therapeutic Production
9.5.1 Europe Giant Cell Arteritis Therapeutic Production Growth Rate (2020-2025)
9.5.2 Europe Giant Cell Arteritis Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Giant Cell Arteritis Therapeutic Production (2020-2025)
9.6.1 Japan Giant Cell Arteritis Therapeutic Production Growth Rate (2020-2025)
9.6.2 Japan Giant Cell Arteritis Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Giant Cell Arteritis Therapeutic Production (2020-2025)
9.7.1 China Giant Cell Arteritis Therapeutic Production Growth Rate (2020-2025)
9.7.2 China Giant Cell Arteritis Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Giant Cell Arteritis Therapeutic Product Overview
10.1.3 Sanofi Giant Cell Arteritis Therapeutic Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 Kiniksa PharmaceuticalsLtd.
10.2.1 Kiniksa PharmaceuticalsLtd. Basic Information
10.2.2 Kiniksa PharmaceuticalsLtd. Giant Cell Arteritis Therapeutic Product Overview
10.2.3 Kiniksa PharmaceuticalsLtd. Giant Cell Arteritis Therapeutic Product Market Performance
10.2.4 Kiniksa PharmaceuticalsLtd. Business Overview
10.2.5 Kiniksa PharmaceuticalsLtd. SWOT Analysis
10.2.6 Kiniksa PharmaceuticalsLtd. Recent Developments
10.3 Regeneron
10.3.1 Regeneron Basic Information
10.3.2 Regeneron Giant Cell Arteritis Therapeutic Product Overview
10.3.3 Regeneron Giant Cell Arteritis Therapeutic Product Market Performance
10.3.4 Regeneron Business Overview
10.3.5 Regeneron SWOT Analysis
10.3.6 Regeneron Recent Developments
10.4 GlaxoSmithKline plc
10.4.1 GlaxoSmithKline plc Basic Information
10.4.2 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Overview
10.4.3 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Market Performance
10.4.4 GlaxoSmithKline plc Business Overview
10.4.5 GlaxoSmithKline plc Recent Developments
10.5 F. Hoffmann-La Roche Ltd.
10.5.1 F. Hoffmann-La Roche Ltd. Basic Information
10.5.2 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Overview
10.5.3 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Market Performance
10.5.4 F. Hoffmann-La Roche Ltd. Business Overview
10.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.6 Novartis AG
10.6.1 Novartis AG Basic Information
10.6.2 Novartis AG Giant Cell Arteritis Therapeutic Product Overview
10.6.3 Novartis AG Giant Cell Arteritis Therapeutic Product Market Performance
10.6.4 Novartis AG Business Overview
10.6.5 Novartis AG Recent Developments
10.7 AbbVieInc.
10.7.1 AbbVieInc. Basic Information
10.7.2 AbbVieInc. Giant Cell Arteritis Therapeutic Product Overview
10.7.3 AbbVieInc. Giant Cell Arteritis Therapeutic Product Market Performance
10.7.4 AbbVieInc. Business Overview
10.7.5 AbbVieInc. Recent Developments
10.8 Bristol-Myers Squibb Company
10.8.1 Bristol-Myers Squibb Company Basic Information
10.8.2 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Overview
10.8.3 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Market Performance
10.8.4 Bristol-Myers Squibb Company Business Overview
10.8.5 Bristol-Myers Squibb Company Recent Developments
10.9 Abbott
10.9.1 Abbott Basic Information
10.9.2 Abbott Giant Cell Arteritis Therapeutic Product Overview
10.9.3 Abbott Giant Cell Arteritis Therapeutic Product Market Performance
10.9.4 Abbott Business Overview
10.9.5 Abbott Recent Developments
10.10 Johnson and Johnson ServicesInc.
10.10.1 Johnson and Johnson ServicesInc. Basic Information
10.10.2 Johnson and Johnson ServicesInc. Giant Cell Arteritis Therapeutic Product Overview
10.10.3 Johnson and Johnson ServicesInc. Giant Cell Arteritis Therapeutic Product Market Performance
10.10.4 Johnson and Johnson ServicesInc. Business Overview
10.10.5 Johnson and Johnson ServicesInc. Recent Developments
10.11 Johns Hopkins Hospital
10.11.1 Johns Hopkins Hospital Basic Information
10.11.2 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Overview
10.11.3 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Market Performance
10.11.4 Johns Hopkins Hospital Business Overview
10.11.5 Johns Hopkins Hospital Recent Developments
10.12 Fortis Healthcare
10.12.1 Fortis Healthcare Basic Information
10.12.2 Fortis Healthcare Giant Cell Arteritis Therapeutic Product Overview
10.12.3 Fortis Healthcare Giant Cell Arteritis Therapeutic Product Market Performance
10.12.4 Fortis Healthcare Business Overview
10.12.5 Fortis Healthcare Recent Developments
10.13 American College of Rheumatology
10.13.1 American College of Rheumatology Basic Information
10.13.2 American College of Rheumatology Giant Cell Arteritis Therapeutic Product Overview
10.13.3 American College of Rheumatology Giant Cell Arteritis Therapeutic Product Market Performance
10.13.4 American College of Rheumatology Business Overview
10.13.5 American College of Rheumatology Recent Developments
10.14 Duke University Health System
10.14.1 Duke University Health System Basic Information
10.14.2 Duke University Health System Giant Cell Arteritis Therapeutic Product Overview
10.14.3 Duke University Health System Giant Cell Arteritis Therapeutic Product Market Performance
10.14.4 Duke University Health System Business Overview
10.14.5 Duke University Health System Recent Developments
10.15 Lahey Clinic Foundation
10.15.1 Lahey Clinic Foundation Basic Information
10.15.2 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Overview
10.15.3 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Market Performance
10.15.4 Lahey Clinic Foundation Business Overview
10.15.5 Lahey Clinic Foundation Recent Developments
11 GIANT CELL ARTERITIS THERAPEUTIC MARKET FORECAST BY REGION
11.1 Global Giant Cell Arteritis Therapeutic Market Size Forecast
11.2 Global Giant Cell Arteritis Therapeutic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Giant Cell Arteritis Therapeutic Market Size Forecast by Country
11.2.3 Asia Pacific Giant Cell Arteritis Therapeutic Market Size Forecast by Region
11.2.4 South America Giant Cell Arteritis Therapeutic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Giant Cell Arteritis Therapeutic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Giant Cell Arteritis Therapeutic Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Giant Cell Arteritis Therapeutic by Type (2026-2033)
12.1.2 Global Giant Cell Arteritis Therapeutic Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Giant Cell Arteritis Therapeutic by Type (2026-2033)
12.2 Global Giant Cell Arteritis Therapeutic Market Forecast by Application (2026-2033)
12.2.1 Global Giant Cell Arteritis Therapeutic Sales (K MT) Forecast by Application
12.2.2 Global Giant Cell Arteritis Therapeutic Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Giant Cell Arteritis Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global Giant Cell Arteritis Therapeutic Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Giant Cell Arteritis Therapeutic Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Giant Cell Arteritis Therapeutic Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Giant Cell Arteritis Therapeutic Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Therapeutic as of 2024)
Table 10. Global Market Giant Cell Arteritis Therapeutic Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Giant Cell Arteritis Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Giant Cell Arteritis Therapeutic Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Giant Cell Arteritis Therapeutic Sales by Type (K MT)
Table 26. Global Giant Cell Arteritis Therapeutic Market Size by Type (M USD)
Table 27. Global Giant Cell Arteritis Therapeutic Sales (K MT) by Type (2020-2025)
Table 28. Global Giant Cell Arteritis Therapeutic Sales Market Share by Type (2020-2025)
Table 29. Global Giant Cell Arteritis Therapeutic Market Size (M USD) by Type (2020-2025)
Table 30. Global Giant Cell Arteritis Therapeutic Market Size Share by Type (2020-2025)
Table 31. Global Giant Cell Arteritis Therapeutic Price (USD/KG) by Type (2020-2025)
Table 32. Global Giant Cell Arteritis Therapeutic Sales (K MT) by Application
Table 33. Global Giant Cell Arteritis Therapeutic Market Size by Application
Table 34. Global Giant Cell Arteritis Therapeutic Sales by Application (2020-2025) & (K MT)
Table 35. Global Giant Cell Arteritis Therapeutic Sales Market Share by Application (2020-2025)
Table 36. Global Giant Cell Arteritis Therapeutic Market Size by Application (2020-2025) & (M USD)
Table 37. Global Giant Cell Arteritis Therapeutic Market Share by Application (2020-2025)
Table 38. Global Giant Cell Arteritis Therapeutic Sales Growth Rate by Application (2020-2025)
Table 39. Global Giant Cell Arteritis Therapeutic Sales by Region (2020-2025) & (K MT)
Table 40. Global Giant Cell Arteritis Therapeutic Sales Market Share by Region (2020-2025)
Table 41. Global Giant Cell Arteritis Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 42. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2020-2025)
Table 43. North America Giant Cell Arteritis Therapeutic Sales by Country (2020-2025) & (K MT)
Table 44. North America Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Giant Cell Arteritis Therapeutic Sales by Country (2020-2025) & (K MT)
Table 46. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Giant Cell Arteritis Therapeutic Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Giant Cell Arteritis Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 49. South America Giant Cell Arteritis Therapeutic Sales by Country (2020-2025) & (K MT)
Table 50. South America Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Giant Cell Arteritis Therapeutic Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 53. Global Giant Cell Arteritis Therapeutic Production (K MT) by Region(2020-2025)
Table 54. Global Giant Cell Arteritis Therapeutic Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2020-2025)
Table 56. Global Giant Cell Arteritis Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Giant Cell Arteritis Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Giant Cell Arteritis Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Giant Cell Arteritis Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Giant Cell Arteritis Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Sanofi Basic Information
Table 62. Sanofi Giant Cell Arteritis Therapeutic Product Overview
Table 63. Sanofi Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Sanofi Business Overview
Table 65. Sanofi SWOT Analysis
Table 66. Sanofi Recent Developments
Table 67. Kiniksa PharmaceuticalsLtd. Basic Information
Table 68. Kiniksa PharmaceuticalsLtd. Giant Cell Arteritis Therapeutic Product Overview
Table 69. Kiniksa PharmaceuticalsLtd. Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Kiniksa PharmaceuticalsLtd. Business Overview
Table 71. Kiniksa PharmaceuticalsLtd. SWOT Analysis
Table 72. Kiniksa PharmaceuticalsLtd. Recent Developments
Table 73. Regeneron Basic Information
Table 74. Regeneron Giant Cell Arteritis Therapeutic Product Overview
Table 75. Regeneron Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Regeneron Business Overview
Table 77. Regeneron SWOT Analysis
Table 78. Regeneron Recent Developments
Table 79. GlaxoSmithKline plc Basic Information
Table 80. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Overview
Table 81. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. GlaxoSmithKline plc Business Overview
Table 83. GlaxoSmithKline plc Recent Developments
Table 84. F. Hoffmann-La Roche Ltd. Basic Information
Table 85. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Overview
Table 86. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. F. Hoffmann-La Roche Ltd. Business Overview
Table 88. F. Hoffmann-La Roche Ltd. Recent Developments
Table 89. Novartis AG Basic Information
Table 90. Novartis AG Giant Cell Arteritis Therapeutic Product Overview
Table 91. Novartis AG Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Recent Developments
Table 94. AbbVieInc. Basic Information
Table 95. AbbVieInc. Giant Cell Arteritis Therapeutic Product Overview
Table 96. AbbVieInc. Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. AbbVieInc. Business Overview
Table 98. AbbVieInc. Recent Developments
Table 99. Bristol-Myers Squibb Company Basic Information
Table 100. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Overview
Table 101. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Bristol-Myers Squibb Company Business Overview
Table 103. Bristol-Myers Squibb Company Recent Developments
Table 104. Abbott Basic Information
Table 105. Abbott Giant Cell Arteritis Therapeutic Product Overview
Table 106. Abbott Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Abbott Business Overview
Table 108. Abbott Recent Developments
Table 109. Johnson and Johnson ServicesInc. Basic Information
Table 110. Johnson and Johnson ServicesInc. Giant Cell Arteritis Therapeutic Product Overview
Table 111. Johnson and Johnson ServicesInc. Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Johnson and Johnson ServicesInc. Business Overview
Table 113. Johnson and Johnson ServicesInc. Recent Developments
Table 114. Johns Hopkins Hospital Basic Information
Table 115. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Overview
Table 116. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Johns Hopkins Hospital Business Overview
Table 118. Johns Hopkins Hospital Recent Developments
Table 119. Fortis Healthcare Basic Information
Table 120. Fortis Healthcare Giant Cell Arteritis Therapeutic Product Overview
Table 121. Fortis Healthcare Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Fortis Healthcare Business Overview
Table 123. Fortis Healthcare Recent Developments
Table 124. American College of Rheumatology Basic Information
Table 125. American College of Rheumatology Giant Cell Arteritis Therapeutic Product Overview
Table 126. American College of Rheumatology Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. American College of Rheumatology Business Overview
Table 128. American College of Rheumatology Recent Developments
Table 129. Duke University Health System Basic Information
Table 130. Duke University Health System Giant Cell Arteritis Therapeutic Product Overview
Table 131. Duke University Health System Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Duke University Health System Business Overview
Table 133. Duke University Health System Recent Developments
Table 134. Lahey Clinic Foundation Basic Information
Table 135. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Overview
Table 136. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Lahey Clinic Foundation Business Overview
Table 138. Lahey Clinic Foundation Recent Developments
Table 139. Global Giant Cell Arteritis Therapeutic Sales Forecast by Region (2026-2033) & (K MT)
Table 140. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Giant Cell Arteritis Therapeutic Sales Forecast by Country (2026-2033) & (K MT)
Table 142. North America Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Giant Cell Arteritis Therapeutic Sales Forecast by Country (2026-2033) & (K MT)
Table 144. Europe Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Giant Cell Arteritis Therapeutic Sales Forecast by Region (2026-2033) & (K MT)
Table 146. Asia Pacific Giant Cell Arteritis Therapeutic Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Giant Cell Arteritis Therapeutic Sales Forecast by Country (2026-2033) & (K MT)
Table 148. South America Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Giant Cell Arteritis Therapeutic Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Giant Cell Arteritis Therapeutic Sales Forecast by Type (2026-2033) & (K MT)
Table 152. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Giant Cell Arteritis Therapeutic Price Forecast by Type (2026-2033) & (USD/KG)
Table 154. Global Giant Cell Arteritis Therapeutic Sales (K MT) Forecast by Application (2026-2033)
Table 155. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Giant Cell Arteritis Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global Giant Cell Arteritis Therapeutic Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Giant Cell Arteritis Therapeutic Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Giant Cell Arteritis Therapeutic Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Giant Cell Arteritis Therapeutic Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Therapeutic as of 2024)
Table 10. Global Market Giant Cell Arteritis Therapeutic Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Giant Cell Arteritis Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Giant Cell Arteritis Therapeutic Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Giant Cell Arteritis Therapeutic Sales by Type (K MT)
Table 26. Global Giant Cell Arteritis Therapeutic Market Size by Type (M USD)
Table 27. Global Giant Cell Arteritis Therapeutic Sales (K MT) by Type (2020-2025)
Table 28. Global Giant Cell Arteritis Therapeutic Sales Market Share by Type (2020-2025)
Table 29. Global Giant Cell Arteritis Therapeutic Market Size (M USD) by Type (2020-2025)
Table 30. Global Giant Cell Arteritis Therapeutic Market Size Share by Type (2020-2025)
Table 31. Global Giant Cell Arteritis Therapeutic Price (USD/KG) by Type (2020-2025)
Table 32. Global Giant Cell Arteritis Therapeutic Sales (K MT) by Application
Table 33. Global Giant Cell Arteritis Therapeutic Market Size by Application
Table 34. Global Giant Cell Arteritis Therapeutic Sales by Application (2020-2025) & (K MT)
Table 35. Global Giant Cell Arteritis Therapeutic Sales Market Share by Application (2020-2025)
Table 36. Global Giant Cell Arteritis Therapeutic Market Size by Application (2020-2025) & (M USD)
Table 37. Global Giant Cell Arteritis Therapeutic Market Share by Application (2020-2025)
Table 38. Global Giant Cell Arteritis Therapeutic Sales Growth Rate by Application (2020-2025)
Table 39. Global Giant Cell Arteritis Therapeutic Sales by Region (2020-2025) & (K MT)
Table 40. Global Giant Cell Arteritis Therapeutic Sales Market Share by Region (2020-2025)
Table 41. Global Giant Cell Arteritis Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 42. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2020-2025)
Table 43. North America Giant Cell Arteritis Therapeutic Sales by Country (2020-2025) & (K MT)
Table 44. North America Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Giant Cell Arteritis Therapeutic Sales by Country (2020-2025) & (K MT)
Table 46. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Giant Cell Arteritis Therapeutic Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Giant Cell Arteritis Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 49. South America Giant Cell Arteritis Therapeutic Sales by Country (2020-2025) & (K MT)
Table 50. South America Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Giant Cell Arteritis Therapeutic Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 53. Global Giant Cell Arteritis Therapeutic Production (K MT) by Region(2020-2025)
Table 54. Global Giant Cell Arteritis Therapeutic Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2020-2025)
Table 56. Global Giant Cell Arteritis Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Giant Cell Arteritis Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Giant Cell Arteritis Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Giant Cell Arteritis Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Giant Cell Arteritis Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Sanofi Basic Information
Table 62. Sanofi Giant Cell Arteritis Therapeutic Product Overview
Table 63. Sanofi Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Sanofi Business Overview
Table 65. Sanofi SWOT Analysis
Table 66. Sanofi Recent Developments
Table 67. Kiniksa PharmaceuticalsLtd. Basic Information
Table 68. Kiniksa PharmaceuticalsLtd. Giant Cell Arteritis Therapeutic Product Overview
Table 69. Kiniksa PharmaceuticalsLtd. Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Kiniksa PharmaceuticalsLtd. Business Overview
Table 71. Kiniksa PharmaceuticalsLtd. SWOT Analysis
Table 72. Kiniksa PharmaceuticalsLtd. Recent Developments
Table 73. Regeneron Basic Information
Table 74. Regeneron Giant Cell Arteritis Therapeutic Product Overview
Table 75. Regeneron Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Regeneron Business Overview
Table 77. Regeneron SWOT Analysis
Table 78. Regeneron Recent Developments
Table 79. GlaxoSmithKline plc Basic Information
Table 80. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product Overview
Table 81. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. GlaxoSmithKline plc Business Overview
Table 83. GlaxoSmithKline plc Recent Developments
Table 84. F. Hoffmann-La Roche Ltd. Basic Information
Table 85. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product Overview
Table 86. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. F. Hoffmann-La Roche Ltd. Business Overview
Table 88. F. Hoffmann-La Roche Ltd. Recent Developments
Table 89. Novartis AG Basic Information
Table 90. Novartis AG Giant Cell Arteritis Therapeutic Product Overview
Table 91. Novartis AG Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Recent Developments
Table 94. AbbVieInc. Basic Information
Table 95. AbbVieInc. Giant Cell Arteritis Therapeutic Product Overview
Table 96. AbbVieInc. Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. AbbVieInc. Business Overview
Table 98. AbbVieInc. Recent Developments
Table 99. Bristol-Myers Squibb Company Basic Information
Table 100. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product Overview
Table 101. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Bristol-Myers Squibb Company Business Overview
Table 103. Bristol-Myers Squibb Company Recent Developments
Table 104. Abbott Basic Information
Table 105. Abbott Giant Cell Arteritis Therapeutic Product Overview
Table 106. Abbott Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Abbott Business Overview
Table 108. Abbott Recent Developments
Table 109. Johnson and Johnson ServicesInc. Basic Information
Table 110. Johnson and Johnson ServicesInc. Giant Cell Arteritis Therapeutic Product Overview
Table 111. Johnson and Johnson ServicesInc. Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Johnson and Johnson ServicesInc. Business Overview
Table 113. Johnson and Johnson ServicesInc. Recent Developments
Table 114. Johns Hopkins Hospital Basic Information
Table 115. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product Overview
Table 116. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Johns Hopkins Hospital Business Overview
Table 118. Johns Hopkins Hospital Recent Developments
Table 119. Fortis Healthcare Basic Information
Table 120. Fortis Healthcare Giant Cell Arteritis Therapeutic Product Overview
Table 121. Fortis Healthcare Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Fortis Healthcare Business Overview
Table 123. Fortis Healthcare Recent Developments
Table 124. American College of Rheumatology Basic Information
Table 125. American College of Rheumatology Giant Cell Arteritis Therapeutic Product Overview
Table 126. American College of Rheumatology Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. American College of Rheumatology Business Overview
Table 128. American College of Rheumatology Recent Developments
Table 129. Duke University Health System Basic Information
Table 130. Duke University Health System Giant Cell Arteritis Therapeutic Product Overview
Table 131. Duke University Health System Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Duke University Health System Business Overview
Table 133. Duke University Health System Recent Developments
Table 134. Lahey Clinic Foundation Basic Information
Table 135. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product Overview
Table 136. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Lahey Clinic Foundation Business Overview
Table 138. Lahey Clinic Foundation Recent Developments
Table 139. Global Giant Cell Arteritis Therapeutic Sales Forecast by Region (2026-2033) & (K MT)
Table 140. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Giant Cell Arteritis Therapeutic Sales Forecast by Country (2026-2033) & (K MT)
Table 142. North America Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Giant Cell Arteritis Therapeutic Sales Forecast by Country (2026-2033) & (K MT)
Table 144. Europe Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Giant Cell Arteritis Therapeutic Sales Forecast by Region (2026-2033) & (K MT)
Table 146. Asia Pacific Giant Cell Arteritis Therapeutic Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Giant Cell Arteritis Therapeutic Sales Forecast by Country (2026-2033) & (K MT)
Table 148. South America Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Giant Cell Arteritis Therapeutic Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Giant Cell Arteritis Therapeutic Sales Forecast by Type (2026-2033) & (K MT)
Table 152. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Giant Cell Arteritis Therapeutic Price Forecast by Type (2026-2033) & (USD/KG)
Table 154. Global Giant Cell Arteritis Therapeutic Sales (K MT) Forecast by Application (2026-2033)
Table 155. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Giant Cell Arteritis Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Giant Cell Arteritis Therapeutic Market Size (M USD), 2024-2033
Figure 5. Global Giant Cell Arteritis Therapeutic Market Size (M USD) (2020-2033)
Figure 6. Global Giant Cell Arteritis Therapeutic Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Giant Cell Arteritis Therapeutic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Giant Cell Arteritis Therapeutic Product Life Cycle
Figure 13. Giant Cell Arteritis Therapeutic Sales Share by Manufacturers in 2024
Figure 14. Global Giant Cell Arteritis Therapeutic Revenue Share by Manufacturers in 2024
Figure 15. Giant Cell Arteritis Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Giant Cell Arteritis Therapeutic Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Giant Cell Arteritis Therapeutic Revenue in 2024
Figure 18. Industry Chain Map of Giant Cell Arteritis Therapeutic
Figure 19. Global Giant Cell Arteritis Therapeutic Market PEST Analysis
Figure 20. Global Giant Cell Arteritis Therapeutic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Giant Cell Arteritis Therapeutic Market Share by Type
Figure 27. Sales Market Share of Giant Cell Arteritis Therapeutic by Type (2020-2025)
Figure 28. Sales Market Share of Giant Cell Arteritis Therapeutic by Type in 2024
Figure 29. Market Size Share of Giant Cell Arteritis Therapeutic by Type (2020-2025)
Figure 30. Market Size Share of Giant Cell Arteritis Therapeutic by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Giant Cell Arteritis Therapeutic Market Share by Application
Figure 33. Global Giant Cell Arteritis Therapeutic Sales Market Share by Application (2020-2025)
Figure 34. Global Giant Cell Arteritis Therapeutic Sales Market Share by Application in 2024
Figure 35. Global Giant Cell Arteritis Therapeutic Market Share by Application (2020-2025)
Figure 36. Global Giant Cell Arteritis Therapeutic Market Share by Application in 2024
Figure 37. Global Giant Cell Arteritis Therapeutic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Giant Cell Arteritis Therapeutic Sales Market Share by Region (2020-2025)
Figure 39. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2020-2025)
Figure 40. North America Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Giant Cell Arteritis Therapeutic Sales Market Share by Country in 2024
Figure 43. North America Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Giant Cell Arteritis Therapeutic Market Size Market Share by Country in 2024
Figure 45. U.S. Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Giant Cell Arteritis Therapeutic Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Giant Cell Arteritis Therapeutic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Giant Cell Arteritis Therapeutic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Giant Cell Arteritis Therapeutic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Giant Cell Arteritis Therapeutic Sales Market Share by Country in 2024
Figure 53. Europe Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Giant Cell Arteritis Therapeutic Market Size Market Share by Country in 2024
Figure 55. Germany Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Giant Cell Arteritis Therapeutic Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Giant Cell Arteritis Therapeutic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Giant Cell Arteritis Therapeutic Market Size Market Share by Region in 2024
Figure 68. China Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Giant Cell Arteritis Therapeutic Sales and Growth Rate (K MT)
Figure 79. South America Giant Cell Arteritis Therapeutic Sales Market Share by Country in 2024
Figure 80. South America Giant Cell Arteritis Therapeutic Market Size and Growth Rate (M USD)
Figure 81. South America Giant Cell Arteritis Therapeutic Market Size Market Share by Country in 2024
Figure 82. Brazil Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Giant Cell Arteritis Therapeutic Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Giant Cell Arteritis Therapeutic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Giant Cell Arteritis Therapeutic Production Market Share by Region (2020-2025)
Figure 103. North America Giant Cell Arteritis Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Giant Cell Arteritis Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Giant Cell Arteritis Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 106. China Giant Cell Arteritis Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Giant Cell Arteritis Therapeutic Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Giant Cell Arteritis Therapeutic Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Giant Cell Arteritis Therapeutic Market Share Forecast by Type (2026-2033)
Figure 111. Global Giant Cell Arteritis Therapeutic Sales Forecast by Application (2026-2033)
Figure 112. Global Giant Cell Arteritis Therapeutic Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Giant Cell Arteritis Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Giant Cell Arteritis Therapeutic Market Size (M USD), 2024-2033
Figure 5. Global Giant Cell Arteritis Therapeutic Market Size (M USD) (2020-2033)
Figure 6. Global Giant Cell Arteritis Therapeutic Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Giant Cell Arteritis Therapeutic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Giant Cell Arteritis Therapeutic Product Life Cycle
Figure 13. Giant Cell Arteritis Therapeutic Sales Share by Manufacturers in 2024
Figure 14. Global Giant Cell Arteritis Therapeutic Revenue Share by Manufacturers in 2024
Figure 15. Giant Cell Arteritis Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Giant Cell Arteritis Therapeutic Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Giant Cell Arteritis Therapeutic Revenue in 2024
Figure 18. Industry Chain Map of Giant Cell Arteritis Therapeutic
Figure 19. Global Giant Cell Arteritis Therapeutic Market PEST Analysis
Figure 20. Global Giant Cell Arteritis Therapeutic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Giant Cell Arteritis Therapeutic Market Share by Type
Figure 27. Sales Market Share of Giant Cell Arteritis Therapeutic by Type (2020-2025)
Figure 28. Sales Market Share of Giant Cell Arteritis Therapeutic by Type in 2024
Figure 29. Market Size Share of Giant Cell Arteritis Therapeutic by Type (2020-2025)
Figure 30. Market Size Share of Giant Cell Arteritis Therapeutic by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Giant Cell Arteritis Therapeutic Market Share by Application
Figure 33. Global Giant Cell Arteritis Therapeutic Sales Market Share by Application (2020-2025)
Figure 34. Global Giant Cell Arteritis Therapeutic Sales Market Share by Application in 2024
Figure 35. Global Giant Cell Arteritis Therapeutic Market Share by Application (2020-2025)
Figure 36. Global Giant Cell Arteritis Therapeutic Market Share by Application in 2024
Figure 37. Global Giant Cell Arteritis Therapeutic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Giant Cell Arteritis Therapeutic Sales Market Share by Region (2020-2025)
Figure 39. Global Giant Cell Arteritis Therapeutic Market Size Market Share by Region (2020-2025)
Figure 40. North America Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Giant Cell Arteritis Therapeutic Sales Market Share by Country in 2024
Figure 43. North America Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Giant Cell Arteritis Therapeutic Market Size Market Share by Country in 2024
Figure 45. U.S. Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Giant Cell Arteritis Therapeutic Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Giant Cell Arteritis Therapeutic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Giant Cell Arteritis Therapeutic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Giant Cell Arteritis Therapeutic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Giant Cell Arteritis Therapeutic Sales Market Share by Country in 2024
Figure 53. Europe Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Giant Cell Arteritis Therapeutic Market Size Market Share by Country in 2024
Figure 55. Germany Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Giant Cell Arteritis Therapeutic Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Giant Cell Arteritis Therapeutic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Giant Cell Arteritis Therapeutic Market Size Market Share by Region in 2024
Figure 68. China Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Giant Cell Arteritis Therapeutic Sales and Growth Rate (K MT)
Figure 79. South America Giant Cell Arteritis Therapeutic Sales Market Share by Country in 2024
Figure 80. South America Giant Cell Arteritis Therapeutic Market Size and Growth Rate (M USD)
Figure 81. South America Giant Cell Arteritis Therapeutic Market Size Market Share by Country in 2024
Figure 82. Brazil Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Giant Cell Arteritis Therapeutic Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Giant Cell Arteritis Therapeutic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Giant Cell Arteritis Therapeutic Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Giant Cell Arteritis Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Giant Cell Arteritis Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Giant Cell Arteritis Therapeutic Production Market Share by Region (2020-2025)
Figure 103. North America Giant Cell Arteritis Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Giant Cell Arteritis Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Giant Cell Arteritis Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 106. China Giant Cell Arteritis Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Giant Cell Arteritis Therapeutic Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Giant Cell Arteritis Therapeutic Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Giant Cell Arteritis Therapeutic Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Giant Cell Arteritis Therapeutic Market Share Forecast by Type (2026-2033)
Figure 111. Global Giant Cell Arteritis Therapeutic Sales Forecast by Application (2026-2033)
Figure 112. Global Giant Cell Arteritis Therapeutic Market Share Forecast by Application (2026-2033)
